MetAlert Completes Corporate Actions and Retains North Equities Corp for Digital Marketing Services 

MetAlert Completes Corporate Actions and Retains North Equities Corp for Digital Marketing Services 

LOS ANGELES CALIFORNIA, October 20, 2022, MetAlert, Inc. (OTC: MLRT), a pioneer in the field of health & safety, wearable GPS human and asset tracking systems, announced it has received final approval from the regulatory bodies and completed all of the corporate actions filed in their 14c on July 19. MetAlert, Inc., formerly known as GTX Corp, is now operating and trading under its new ticker symbol MLRT.

As part of its marketing strategy, MetAlert, has also retained North Equities Corp to provide digital marketing services aimed at building awareness of its rebranding and positioning in the medical device, telehealth, and remote patient monitoring (RPM) industry.

Patrick Bertagna, MetAlert CEO, commented on this development by saying, “We believe that North Equities brings unique skills and expertise that will help strengthen our existing team, as we continue to grow and build recognition in the marketplace. We are excited about the possibilities that lie ahead and with our team’s expertise in digital marketing and keen focus on strategic brand building, we look forward to achieving great things in the future as we navigate the ever-changing markets of today.”

Since the rebranding went effective MetAlert has received a significant amount of media coverage both domestically and internationally. The Company was mentioned in dozens of U.S. media outlets including FOX News, ABC News, CBS News, NBC News, Yahoo Finance, NY Business Digest, PubCo Insights, Belmont Star, Herald Market and Security Solutions Watch. Internationally, MetAlert news was reported in Mexico, Canada, Japan, India, Thailand, Brazil, Germany, and New Zealand. 

Link to the recent MetAlert Media Coverage Index.

Recent Stock Day Podcast Interview 

K9 Gold Corp. | Genflow Biosciences Plc Stock Day Media

K9 Gold Corp. (TSXV: KNC) (FSE: 5GP) (OTCQB: WDFCF) is pleased to report a significant upgrade to the Moonlight target on its Stony Lake Project in central Newfoundland. The 2023 soil sampling program has both widened and enhanced the target area at Moonlight. The 2023 exploration program on the project comprised the collection of 311 soil samples on two grids, Moonlight and Rattling Brook. Field work was performed by GroundTruth Exploration, of Dawson City, YK. Genflow Biosciences Plc (LSE:GENF) (OTCQB:GENFF), an emerging leader in the field of longevity research developing therapeutics that potentially halt or slow the ageing process is pleased to provide a year-end review and summary of its progress during 2023 and defined strategic priorities for 2024. For more information, please visit StockDayMedia.com

The Company has several scheduled interviews in the coming weeks and will continue its media campaign to increase brand awareness for MetAlert and explain its broader vison centered around solutions that improve health, safety, wellness, longevity, and quality of life. 

For all press or sales inquiries, please contact us at info@metalert.com 

About MetAlert, Inc.

MetAlert (OTC: MLRT) and its subsidiaries occupy a commanding position in the design, development, manufacturing, distribution, sales, and licensing of GPS wearable technology, asset recovery services, wandering assistive technology, and health data collection and monitoring. With over two decades of industry expertise and a robust portfolio of patents, MetAlert is the go-to solution provider for consumers and patients grappling with mobility, cognitive, and spatial awareness challenges. This demographic represents approximately 2.9% of the global population. The Company delivers comprehensive global solutions encompassing logistics, hardware, software, and connectivity.

Notable achievements include the groundbreaking GPS SmartSole®, a fusion of Dr. Scholl’s comfort with LoJack’s tracking prowess. It stands as the world’s inaugural invisible wearable tracking device, designed for individuals susceptible to wandering due to Alzheimer’s, dementia, autism, and traumatic brain injury. MetAlert’s subscription-based model thrives on technology innovation fortified by intellectual property safeguards. The company boasts international distribution channels serving customers across 40 countries, alongside its role as a U.S. Military Government contractor. In addition to public health entities, MetAlert caters to municipalities, emergency and law enforcement agencies, private educational institutions, assisted living facilities, NGOs, senior care residences, consumers, and small enterprises. Recognizing its excess capacity within its distribution center and backend processes also presents an opportunity to expand revenue streams and diversify its operations.

General information, investor relations, wholesale licensing, consumer purchase:

213.489.3019  | Info@MetAlert.com | IR@MetAlert.com | Contact Us

 MetAlert.com | Mygunalert.com | Track My Workforce | GPS SmartSole.com 

MetAlert United Kingdom– In the UK, MetAlert operates from its London office.

Please contact: Nelson Skip Riddle | Email: NSRiddle@MetAlert.com | Tel: +44 7785 364100

Level 2 Security (Wholly owned subsidiary) Email: contactus@level2sec.com | www.mygunalert.com | www.ifitmoves.com

Become a Brand Ambassador

Forward Looking Statements

This news release contains forward-looking statements. The terms and phrases “expects,” “would,” “will,” “believes,” and similar terms and phrases are intended to identify these forward-looking statements. Forward-looking statements are based on estimates and assumptions made by MetAlert considering its experience and perception of current conditions and expected future developments, as well as other factors that MetAlert believes are appropriate in the circumstances. Many factors could cause MetAlert’s actual results, performance, or achievements to differ materially from those expressed or implied by the forward-looking statements. Certain risk factors that may cause actual results to differ are outlined in MetAlert’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (which may be obtained on the SEC Website). These factors should be considered carefully, and readers should not rely on MetAlert’s forward-looking statements. MetAlert has no intention and undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required.

Disclaimer: MetAlert does not warrant or represent that the unauthorized use of materials drawn from this document’s content will not infringe the rights of third parties who are not owned or affiliated by MetAlert. Further, MetAlert cannot be held responsible or liable for the unauthorized use of this document’s content by third parties unknown to the company.